Message from Icon Oncology CEO on COVID-19
Spotlight on value, cost and outcomes for cancer patients in SA
The 5th biennial Independent Clinical Oncology Network (ICON) conference to be staged in Cape Town later this year will address key issues around delivering quality treatment at a reasonable cost, and in turn providing an improved quality of life for patients in South Africa.
ICON, born out of the desire to ensure wider access of cancer care to more patients, has developed evidence-based clinical protocols that are updated regularly to keep up with advances in cancer care. Its conferences seek to underline its efforts and give professionals an opportunity to share knowledge and network.
“The ICON conference is unique in that it is an in-house meeting with a strong academic focus and it has parallel streams that recognise that managing a cancer patient and their family holistically is a multidisciplinary team effort. For this reason, ICON includes the services that support oncologists in the management of their cancer patients, including oncology nurses, radiotherapists, medical physicists, oncology social workers and practice management,” says Dr David Eedes, Clinical Oncology Advisor for ICON.
This year’s ICON conference, themed ‘Unlocking value: Optimising outcomes’ emphasises the importance of clinical outcome measurement and reporting in determining the value delivered to patients and will review how ICON scales the outcomes of patient care and treatment as well as reward delivery of value treatment.
With expert local and international speakers, as well as representation by the funding and pharmaceutical industries; delegates to the conference will gain broad insight from across the oncology ecosystem. The speakers will include:
• Prof. Mary Gospodarowicz, a Professor at the University of Toronto, Medical Director of Princess Margaret Cancer Centre and Regional Vice President of Cancer Care. Prof. Gospodarowicz will present on issues such as outcomes collection; sequencing of agents in high risk metastatic disease and cancer survivorship.
• Prof. Yolande Lievens, Chair of the Radiation Oncology Department of the Ghent University Hospital in Belgium, and associate professor at the Ghent University. Prof. Yolande Lievens will discuss the roadmap of Health Economics in Radiation Oncology (HERO) Program, Relevant outcomes and Global Impact of Radiation in Oncology (GIRO) Partnership and QA/QM initiatives in Europe: The ESTRO vision.
• Dr Russell Hoverman, Vice President for Quality Programs for Texas Oncology and Medical Director of Innovent Oncology in the US Oncology Network. He will present on oncology care models, logic, implementation and pitfalls of transformation; and ‘Why is end of life care so hard?’
• Prof. Bryan Burmeister, a radiation oncologist based at University of Queensland who practises at the Princess Alexandra Hospital in Brisbane, Australia. He will present on developing protocols: Queensland experience for bladder cancer; optimising outcomes for lung cancer using radiotherapy and developing protocols for the assessment of new treatments and technologies.
“Central to the successes of the ICON Conference is the involvement of the network; not only as delegates, but also as presenters and chairs of sessions. This meeting aspires to inspire and consolidate the network in its focus and energy to achieve the best for our cancer patients,” says Jacques Snyman, Chief Executive Officer of Medical Specialist Holdings (MSH), the holding company of ICON.
ICON’s fifth conference will be held from the 17th August to 19th August 2018 at the Century City Conference Centre in Cape Town. To register, please visit the conference website: www.icon2018.co.za